Noble James 4
4 · GW PHARMACEUTICALS PLC · Filed Feb 24, 2021
Insider Transaction Report
Form 4
Noble James
Director
Transactions
- Award
Share Options
2021-02-22+22,464→ 22,464 totalExercise: $0.00Exp: 2031-02-22→ Ordinary Shares (22,464 underlying)
Footnotes (4)
- [F1]Granted pursuant to the Issuer's Long-Term Incentive Plan
- [F2]Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021.
- [F3]These share options will vest in three equal annual installments beginning on February 22, 2022.
- [F4]Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc.